Description

SUMINAT 100 MG

Indications

SUMINAT 100 MG is primarily indicated for the acute treatment of migraine attacks with or without aura in adults. It is effective in alleviating the symptoms associated with migraine headaches, including severe headache, nausea, and sensitivity to light and sound. SUMINAT is not intended for the preventive treatment of migraines nor for the treatment of other types of headaches.

Mechanism of Action

The active ingredient in SUMINAT is sumatriptan, which belongs to a class of medications known as triptans. Sumatriptan works by stimulating serotonin (5-HT) receptors in the brain, specifically the 5-HT1B and 5-HT1D subtypes. This action leads to vasoconstriction of dilated cranial blood vessels and inhibition of pro-inflammatory neuropeptide release, effectively reducing the migraine headache and associated symptoms. By targeting these specific receptors, SUMINAT can provide rapid relief from migraine symptoms.

Pharmacological Properties

SUMINAT 100 MG is rapidly absorbed after oral administration, with peak plasma concentrations typically reached within 1 to 2 hours. The bioavailability of sumatriptan is approximately 14% due to extensive first-pass metabolism in the liver. The drug is primarily metabolized by monoamine oxidase (MAO) and has a half-life of about 2.5 hours. Excretion occurs mainly through the urine, with both unchanged drug and metabolites present. The pharmacokinetics of sumatriptan can be influenced by factors such as age, liver function, and co-administration of other medications.

Contraindications

SUMINAT 100 MG is contraindicated in patients with a known hypersensitivity to sumatriptan or any of its excipients. It should not be used in individuals with a history of ischemic heart disease, coronary artery vasospasm, or uncontrolled hypertension. Additionally, SUMINAT is contraindicated in patients who have taken monoamine oxidase inhibitors (MAOIs) within the last 14 days, as this can lead to serious cardiovascular side effects. Caution should also be exercised in patients with a history of seizures or those at risk of seizures.

Side Effects

Common side effects associated with SUMINAT 100 MG include dizziness, drowsiness, flushing, and a sensation of tightness or pressure in the chest or throat. Other potential side effects may include nausea, vomiting, and fatigue. While most side effects are mild and transient, serious adverse effects such as myocardial infarction, stroke, or severe allergic reactions can occur, albeit rarely. Patients should be advised to seek immediate medical attention if they experience chest pain, shortness of breath, or severe allergic reactions.

Dosage and Administration

The recommended dose of SUMINAT 100 MG for adults is one tablet taken orally at the onset of a migraine attack. If the migraine symptoms do not improve, a second dose may be taken after at least 2 hours. However, the total daily dose should not exceed 300 mg. It is important to note that SUMINAT should not be used for more than 10 days per month to avoid medication overuse headaches. Patients are advised to follow their healthcare provider’s instructions regarding dosing, and to not exceed the recommended dosage.

Interactions

SUMINAT 100 MG may interact with other medications, leading to increased risk of adverse effects. Concomitant use of other triptans or ergotamine-containing medications is contraindicated due to the potential for additive vasoconstrictive effects. Additionally, caution should be exercised when sumatriptan is used with selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs), as this may increase the risk of serotonin syndrome. Patients should inform their healthcare provider of all medications they are taking, including over-the-counter drugs and herbal supplements.

Precautions

Before starting treatment with SUMINAT 100 MG, patients should be thoroughly evaluated for cardiovascular risk factors, especially if they have a history of heart disease or risk factors such as hypertension, diabetes, or smoking. It is essential to monitor patients for signs of cardiovascular events, particularly after the first dose. Caution is also advised in patients with hepatic impairment, as this may affect the metabolism of sumatriptan. Pregnant or breastfeeding women should consult their healthcare provider before using SUMINAT, as the safety of sumatriptan in these populations has not been fully established.

Clinical Studies

Numerous clinical studies have demonstrated the efficacy of SUMINAT 100 MG in treating acute migraine attacks. In randomized controlled trials, sumatriptan has been shown to significantly reduce headache severity and improve associated symptoms such as nausea and photophobia compared to placebo. One study published in the journal “Headache” found that SUMINAT provided relief within 30 minutes for a significant percentage of patients, with sustained relief lasting for several hours. These findings support the use of SUMINAT as a first-line treatment option for acute migraine attacks.

Conclusion

SUMINAT 100 MG is an effective treatment option for adults experiencing acute migraine attacks. Its mechanism of action through serotonin receptor stimulation allows for rapid relief of migraine symptoms. While generally well-tolerated, it is essential for patients to be aware of potential side effects, contraindications, and drug interactions. Proper patient education and adherence to dosing guidelines are crucial for maximizing the benefits of this medication while minimizing risks. As with any medication, individuals should consult their healthcare provider for personalized advice and treatment plans.